Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
66 Cards in this Set
- Front
- Back
what is multiple sclerosis?
|
autoimmune disease (CD4 and Th1 dysregulation) characterized by demyelination of the CNS and axonal loss
|
|
list some common facts/statements about the etiology and epidemiology.
|
genetics (HLA-DR2 and TCR) and environment plays a role (Demographics: further from the equator = more likely to get MS; microbial, Toxins); 200 new cases a week in the US; most common cause of non-traumatic disability in young adults; affects women more often; usual age onset 20-30s;
|
|
explain molecular mimicry.
|
it is where antigens evoking an immune response have similarities to the body's own proteins and cause an immune rxn; body's inability to distinguish self from non-self; some common non-self antigens (viruses and bacteria/toxins) and potential self antigens (myelin basic protein - looks like a virus - may be the problem)
|
|
name the four types of MS.
|
1) Benign MS; 2) Relapsing Remitting MS; 3) Secondary Progressive; 4) Primary Progressive
|
|
name the man responsible for giving us the first signs and symptoms of multiple sclerosis.
|
Jean-Martin Charcot
|
|
which type of MS doesn't cause cognitive problems but is mainly gait issues; it doesn't follow the typical MS spectrum.
|
Primary Progressive MS - typically males and mainly gait difficulties
|
|
at diagnosis most people are this type?? and develop into ___________ in 11-15 years.
|
at diagnosis most(85%) are relapsing remitting and develop into 58%-secondary-progressive or 42% stay relapsing remitting
|
|
what two factors will cause an MS patient to stop working?
|
fatigue and cognition problems
|
|
MS has been thought to be a dual phase disease. what are the stages.
|
inflammatory --> progressing --> to Degenerative
|
|
as an MS patient progresses from preclinical --> relapsing --> secondary progressive, how does the brain grossly change?
|
as the disease progresses, the ventricles enlarge and the brain atrophies
|
|
name the disability scale used to grade the MS disability.
|
EDSS (expanded disability status scale); 0-10; 10 is death; defined by functional, walking, and dependence; scores of 0-6 are subtle changes, once a pt is beyond a 6 the changes are very noticable
|
|
what are the 3 major groups of cells that are possibly involved in MS?
|
1) Tcell/Macrophage; 2) Antibody/Complement; 3) oligodendrocytes
|
|
53% of MS patients follow the pattern of having problems with which groups of cells?
|
tcell/macrophage and Antibody/complement are involved, but the oligodendrocytes are normal
|
|
how will MS axonal loss lesions show up on T1 MRI?
|
hypointense
|
|
CD4 Tcells differentiate into Th1 and Th2 cells. what do Th1 and Th2 cells produce?
|
Th1: pro-inflammatory cytokines (IL-2, IFN, TNF) macrophage mediated; Th2: anti-inflammatory cytokines (IL-4, IL-5, IL-10, IL-13) Bcell mediated
|
|
name the newer way to measure MS functionality. it uses a 25 foot walk, a nine-hole peg test, and a PASAT (paced auditory serial addition test).
|
MSFC, Multiple Sclerosis Functional Composite
|
|
what are the diagnostic tools used to diagnose MS?
|
H&P, MRI of brain and spinal cord, CSF exam, Evoked Potentials (SSEP, VEP, BAER), and other labs
|
|
on MRI, where are the lesions?
|
most are typically paraventricular
|
|
is it possible to have MS and be asymptomatic but not have lesions?
|
not normally, axonal damage/inflammatory lesions are common to see on MRI even without symptoms; for every one relapse there are 5-10 inflammatory lesions on MRI
|
|
when ordering an MRI, what technique do you want?
|
3mm thick sections, no more than a 1mm skip, axial and sagittal FLAIR, wait at least 5 min between contrast and filming
|
|
name some diseases that mimic MS.
|
Devic's Disease (just neuromyelitis optica); sarcoidosis, Sjogren's, Behcet S, Leukodystrophies of adulthood, PML, ADEM, Lyme dz, primary CNS vasculitis, tertiary syphilis, CADASIL, antiphospholipid syndrome
|
|
define the diagnostic criteria of Devic's Dz (mimic of MS).
|
1) optic and transverse myelitis; 2) Two of the following: a) MRI evidence of contiguous spinal cord lesion 3 or more segments long; b) brain MR is not consistant with MS; c) NMO-IgG seropositivity (NeuroMyelitis Optica - NMO)
|
|
If a young adult patient presents with confusion, gait disturbances, seizures, headaches, with bowel/bladder problems after an acute infection, what do you think of?
|
ADEM Acute Disseminated Encephalomyelitis: will reveal an abnormal brain/cord MRI with multiple enhancing lesions; CSF: increase protein, pleocytosis, and no Oligoclonal bands; usually monophasic
|
|
this MS mimicing dz is a reactivation of JC virus commonly presented in immunocompromised patients. also, what MS drug may cause this to occur?
|
PML - progressive multifocal leukoencephalopathy; the MS drug of last resort is Natalizumab
|
|
even if a patient is labeled CIS (clinically isolated syndrome) it may be important to start therapy (controversial) since axonal loss may occur early. if a patient has CIS with optic neuritis, what puts that patient at increased and/or decreased risk?
|
INCREASED RISK of developing MS: young adult, female, unilateral, pain, normal disc, brain lesions, abnormal CSF (OCBs, increased leukocytes, protein, myelin basic protein, normal glucose); DECREASED RISK: children, male, bilateral, painless, severe disc edema, normal brain MRI, Normal CSF
|
|
what are the increased and decreased risk factors of developing MS after an episode of Transverse myelitis?
|
INCREASED: incomplete TM, asymmetric sx, abnormal brain MRI, OCB in CSF, no CSF pleocytosis, smaller cord lesion, no edema; DECREASED RISK: complete TM, symmetric sx, normal brain MRI, no OCB in CSF, CSF pleocytosis, multi-segments, and edema
|
|
name the two criteria methods used to diagnose MS after CIS.
|
1) Poser Criteria: need evidence of 2 separate attacks (1st is the CIS, 2nd is confirming); 2) McDonald Criteria: since MRI can be abnormal and pt asymptomatic, this criteria uses MRI as the defining 2nd event
|
|
What is found in the CSF of an MS patient that is sensitive and specific?
|
OCB (oligoclonal bands)
|
|
there are 3 ways to medically manage MS, name them.
|
1) treat the relapses, 2) manage the symptoms, 3) alter the course of MS
|
|
common causes for an MS exacerbation or flare up are:
|
new illness, fever
|
|
name the common steroid treatments for MS relapses.
|
Solumedrol (methylprednisolone); oral prednison; ACTH
|
|
management of MS patients should include treating the symptoms, name common ones.
|
pain (present in 70%), spasticity (tizanidine), bladder/bowel problems, mood, cognitive dysfxn, fatigue (improve quality of life!)
|
|
what is the most common symptom in MS?
|
Fatigue is seen in 90% of pts; listed as disabling in 50% (lassitude is the term used to define tiredness not related to activity); fatigue is heat sensitive and occurs in specific muscle groups after use
|
|
name the phenomenon where symptoms show up after an increase in body temperature.
|
Uthoff's Phenomenon
|
|
what do activated t-cells express to cross the BBB? what happens if the naive t-cell finds an antigen that it is specific for?
|
activated t-cells express VLA-4 and are able to cross the BBB because the endothelial cells express VCAM-1 and ICAM; if these activated tcells encounter the antigen to which they are specific, they will form effector cells and either secrete pro-inflammatory cytokines (CD4) or kill myelin (cytotoxic CD8)
|
|
what types of cells vary in early vs late lesions?
|
early lesions have predominately tcells especially CD4 cells (inflammation); chronic lesions: macrophages and microglial predominate with loss of oligodendrocytes and axons (CD8 predominate in chronic)
|
|
the gene with the strongest link to MS is what?
|
the MHC, particularly the HLA-DR2 (class II HLA are expressed on antigen presenting cells, dendritic cells, activated macrophages, Bcells) - class II allow CD4 cells to attach
|
|
what do CD4 cells predominately secrete?
|
cytokines: gamma IFN, TNF, and IL-2 (promote mononuclear infiltrate, recruite cytotoxic Tcells, macrophages, adn NK cells into the area)
|
|
what do the anti-myelin CD8 cells do?
|
attach to class I antigens of oligodendrocytes and cause damage
|
|
what is the role of glial cells?
|
normally glial cells are the macrophages of the nervous system; microglial cells present antigens to t-cells; activated glial cells proliferate and express MHC I and II, co-stimulatory molecules for CD8 and CD4 activation.
|
|
explain the role of astrocytes in MS.
|
normally astrocytes maintain the BBB. In MS they are induced to proliferate because of the damage, this causes an astrocyte scar to form, this is a typical lesion in an MS patient. both astrocytes and oligodendrocytes can be induced by cytokines to express MHC II antigens and participate in antigen presention to CD4 cells
|
|
CD4 secrete IFN, TNK, IL-2. what do they do to myelin?
|
TNF and gamma IFN damage myelin
|
|
what tolerance mechanism may be dysfunctional in MS?
|
central tolerance may be dysfxnal. normally, central tolerance prevents t-cells from having specificity to self
|
|
name some commonly suggested microorganism/viruses that may play a role in MS.
|
EBV, HHV-6, retroviruses, chlamydia pneuoniae
|
|
how infectious agents cause MS is uncertain, but ____________ is the most commonly offered explanation.
|
molecular mimicry (it is where antigens evoking an immune response have similarities to the body's own proteins and cause an immune rxn)
|
|
normally, there are __________________ protecting the integrity of the BBB.
|
tight junctions
|
|
overall, if you had a choice of what type of t-cell (Th1 or Th2) you could put into the CNS of a MS pt, which would it be and why?
|
since MS has inflammatory component, you would want to add or stimulate the activation of Th2 cells since they release anti-inflammatory cytokines like IL-10
|
|
what is the microglia's role in lesion formation and lesion repair?
|
formation: secretes inflammatory mediators and presents antigens to CD4 cells; REPAIR: secretes growth factors that promote remyelination
|
|
what is the endothelial's role in lesion formation and lesion repair?
|
formation of lesion: recruit mononuclear cells, antigen presentation; REPAIR: maintain BBB
|
|
what is the macrophage's role in lesion formation and lesion repair?
|
formation: secretion of cytokines and mediators which degrade myelin; antigen presentation to CD4 cells; REPAIR: secrete anti-inflammatory cytokines IL10, TGFb
|
|
once in the brain, t cells secrete _________ that assist in their migration and degrade type 4 collagen, thereby causing damage to the BBB; it also induces proteolysis of myelin sheath.
|
MMP-9: matrix metalloproteases
|
|
name the three main categories of treatment meds for MS patients.
|
1) IMMUNOMODULATORS: BETA-IFNs: avonex, betaseron, rebif; glatiramer acetate; natalizumab; 2) CORTICOSTEROIDS: methylpredisolone; 3) IMMUNOSUPPRESSORS: mitoxantrone, cyclophasphamide, azathioprine, methotrexate
|
|
What is glatiramer acetate and its MOA?
|
immunomodulator; copolymer of 4 amino acids; similar in structure to myelin basic protein; suggested to secrete anti-inflammatory cytokines (IL-4, IL-10, TGF-b) by TH2 t-cells
|
|
corticosteroids are manily used to treat what in MS?
|
significant relapses; symptomatic management; inhibit pro-inflammatory cytokines
|
|
the immunomodulators (beta-IFN) are usually indicated to do what in MS?
|
to lower the number of relapses and stop progression; the reduce the activation of Tcells
|
|
what is the proposed role in the immunomodulator, natalizumab and what may it cause that would most likely be lethal?
|
natalizumab is the drug of last resort for MS patients; most likely it works as an antibody to the alpha 4 subunit of the VLA-4 on activated T-cells (that bind to VCAM on endothelial cells)
|
|
define primary progressive MS.
|
progressive deterioration without relapses and remissions, there are occasional plateus and temporary minor improvements; mainly have gait problems
|
|
define progressive-relapsing (PRMS).
|
rare, progressive from onset with acute relapses that may or may not result in complete recovery
|
|
Name the immunomodulators used to treat MS.
|
Betaseron, Avonex, Rebif, glatiramer acetate
|
|
name the immunosuppressors used to treat MS.
|
mitoxantrone
|
|
explain the MOA of interferon beta.
|
reduce production of TNFa, T-cells; reduce inflammation by switching to more TH2 cells and increasing levels of IL-10; decrease antigen presentation, reduce ability of cells to cross the BBB
|
|
what are the indications of using Avonex, Rebif ( both interferon B-1a) and Betaseron (interferon beta-1b) on MS pts?
|
use in relapsing forms, one IM shot weekly for Avonex and 3 subc shots for Rebif and subc every other day in Betaseron; reduces relapse rate and development of new lesions
|
|
List some common side-effects of interferons.
|
flu-like symptoms, chills, fever, muscle aches, asthenia, possible injection site rxn
|
|
name the immunomodulator that is not an interferon.
|
glatiramer acetate (less s/e than interferons but may cause chest pains)
|
|
name the anitneoplastics/immunosuppresants indications and Side-effects?
|
mitoxantrone: reduction of relapse rate and clinical disability; mainly used for progressive MS; IV infusion every 3months; S/E: bone marrow suppression, cardiac tox, teratogenic effects,
|
|
what is the astrocyte's role in lesion formation and lesion repair?
|
formation: secretes inflammatory mediators and presents antigens to CD4 cells; REPAIR: secretes growth factors that promote remyelination
|